FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028692430> ?p ?o ?g. }

• W2028692430 endingPage "11" @default.
• W2028692430 startingPage "1" @default.
• W2028692430 abstract "Lenalidomide is an immunomodulatory drug with therapeutic activity in chronic lymphocytic leukemia (CLL). However, it has pleiotropic effects, and the mechanism of action responsible for its therapeutic activity has not been well defined yet. Herein, we show that lenalidomide treatment does not have an effect on the proliferation of leukemia cells, but it increases the proliferation of B cells from healthy donors. Lenalidomide did not exert a direct effect on the apoptosis of leukemia cells obtained from CLL patients, although it indirectly induced their apoptosis through the activation of nonmalignant immune cells. Thus, lenalidomide markedly increased the proliferation of NK and CD4 T cells. The effect of lenalidomide on NK cells was secondary to the induction of IL-2 production by CD4 T cells. Accordingly, depletion of T cells or blockade of IL-2 activity completely abrogated the proliferation of NK cells. Additionally, lenalidomide enhanced NK and NKT-like cell-mediated natural cytotoxicity against leukemia cells from CLL patients. Lenalidomide also upregulated CD20 expression on leukemia cells and, accordingly, it had a synergistic effect with rituximab on promoting antibody-dependent cell-mediated cytotoxicity against primary leukemia cells. Overall, these observations provide a support for combining lenalidomide with rituximab as a treatment in CLL." @default.
• W2028692430 created "2016-06-24" @default.
• W2028692430 creator A5010978051 @default.
• W2028692430 creator A5033968461 @default.
• W2028692430 creator A5045769320 @default.
• W2028692430 creator A5051586326 @default.
• W2028692430 creator A5062126850 @default.
• W2028692430 creator A5071261900 @default.
• W2028692430 creator A5079825036 @default.
• W2028692430 date "2014-01-01" @default.
• W2028692430 modified "2023-10-16" @default.
• W2028692430 title "Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells" @default.
• W2028692430 cites W1498187417 @default.
• W2028692430 cites W1538172952 @default.
• W2028692430 cites W1719336338 @default.
• W2028692430 cites W1980068016 @default.
• W2028692430 cites W2012721290 @default.
• W2028692430 cites W2012959199 @default.
• W2028692430 cites W2017009058 @default.
• W2028692430 cites W2017456279 @default.
• W2028692430 cites W2025741975 @default.
• W2028692430 cites W2033556677 @default.
• W2028692430 cites W2049869153 @default.
• W2028692430 cites W2052041910 @default.
• W2028692430 cites W2060496777 @default.
• W2028692430 cites W2060813234 @default.
• W2028692430 cites W2066815159 @default.
• W2028692430 cites W2068283826 @default.
• W2028692430 cites W2081654383 @default.
• W2028692430 cites W2088619423 @default.
• W2028692430 cites W2099308699 @default.
• W2028692430 cites W2106233921 @default.
• W2028692430 cites W2120775216 @default.
• W2028692430 cites W2126642894 @default.
• W2028692430 cites W2136242714 @default.
• W2028692430 cites W2138039718 @default.
• W2028692430 cites W2142099365 @default.
• W2028692430 cites W2154108455 @default.
• W2028692430 cites W2154553633 @default.
• W2028692430 cites W2253342312 @default.
• W2028692430 doi "https://doi.org/10.1155/2014/265840" @default.
• W2028692430 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4182694" @default.
• W2028692430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25313353" @default.
• W2028692430 hasPublicationYear "2014" @default.
• W2028692430 type Work @default.
• W2028692430 sameAs 2028692430 @default.
• W2028692430 citedByCount "46" @default.
• W2028692430 countsByYear W20286924302015 @default.
• W2028692430 countsByYear W20286924302016 @default.
• W2028692430 countsByYear W20286924302017 @default.
• W2028692430 countsByYear W20286924302018 @default.
• W2028692430 countsByYear W20286924302019 @default.
• W2028692430 countsByYear W20286924302020 @default.
• W2028692430 countsByYear W20286924302021 @default.
• W2028692430 countsByYear W20286924302022 @default.
• W2028692430 countsByYear W20286924302023 @default.
• W2028692430 crossrefType "journal-article" @default.
• W2028692430 hasAuthorship W2028692430A5010978051 @default.
• W2028692430 hasAuthorship W2028692430A5033968461 @default.
• W2028692430 hasAuthorship W2028692430A5045769320 @default.
• W2028692430 hasAuthorship W2028692430A5051586326 @default.
• W2028692430 hasAuthorship W2028692430A5062126850 @default.
• W2028692430 hasAuthorship W2028692430A5071261900 @default.
• W2028692430 hasAuthorship W2028692430A5079825036 @default.
• W2028692430 hasBestOaLocation W20286924301 @default.
• W2028692430 hasConcept C159654299 @default.
• W2028692430 hasConcept C18031839 @default.
• W2028692430 hasConcept C203014093 @default.
• W2028692430 hasConcept C2776063141 @default.
• W2028692430 hasConcept C2776364478 @default.
• W2028692430 hasConcept C2777938653 @default.
• W2028692430 hasConcept C2778461978 @default.
• W2028692430 hasConcept C40677261 @default.
• W2028692430 hasConcept C502942594 @default.
• W2028692430 hasConcept C542903549 @default.
• W2028692430 hasConcept C71924100 @default.
• W2028692430 hasConcept C86803240 @default.
• W2028692430 hasConcept C8891405 @default.
• W2028692430 hasConcept C98274493 @default.
• W2028692430 hasConceptScore W2028692430C159654299 @default.
• W2028692430 hasConceptScore W2028692430C18031839 @default.
• W2028692430 hasConceptScore W2028692430C203014093 @default.
• W2028692430 hasConceptScore W2028692430C2776063141 @default.
• W2028692430 hasConceptScore W2028692430C2776364478 @default.
• W2028692430 hasConceptScore W2028692430C2777938653 @default.
• W2028692430 hasConceptScore W2028692430C2778461978 @default.
• W2028692430 hasConceptScore W2028692430C40677261 @default.
• W2028692430 hasConceptScore W2028692430C502942594 @default.
• W2028692430 hasConceptScore W2028692430C542903549 @default.
• W2028692430 hasConceptScore W2028692430C71924100 @default.
• W2028692430 hasConceptScore W2028692430C86803240 @default.
• W2028692430 hasConceptScore W2028692430C8891405 @default.
• W2028692430 hasConceptScore W2028692430C98274493 @default.
• W2028692430 hasFunder F4320309086 @default.
• W2028692430 hasLocation W20286924301 @default.
• W2028692430 hasLocation W20286924302 @default.
• W2028692430 hasLocation W20286924303 @default.
• W2028692430 hasLocation W20286924304 @default.

• next